Genetic variation inUGTgenes modify the associations of NSAIDs with risk of colorectal cancer: Colon cancer family registry
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic variation inUGTgenes modify the associations of NSAIDs with risk of colorectal cancer: Colon cancer family registry
Authors
Keywords
-
Journal
GENES CHROMOSOMES & CANCER
Volume 53, Issue 7, Pages 568-578
Publisher
Wiley
Online
2014-03-28
DOI
10.1002/gcc.22167
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effect of copy number variation in the phase II detoxification genesUGT2B17andUGT2B28on colorectal cancer risk
- (2013) Andrea Y. Angstadt et al. CANCER
- Aspirin and Colorectal Cancer: Back to the Future
- (2013) David Tougeron et al. CLINICAL CANCER RESEARCH
- Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia
- (2013) Sarah E. Kleinstein et al. GENES CHROMOSOMES & CANCER
- Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
- (2013) Dora Colussi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial
- (2013) Sarah Kraus et al. Pharmacogenetics and Genomics
- Aspirin and Cancer Prevention and Treatment: Are We There Yet?
- (2012) J. D. Potter CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Association of Uridine Diphosphate-Glucuronosyltransferase 2B Gene Variants with Serum Glucuronide Levels and Prostate Cancer Risk
- (2012) Delores J. Grant et al. Genetic Testing and Molecular Biomarkers
- Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms
- (2012) Whay Kuang Chia et al. Nature Reviews Clinical Oncology
- Meta-Analysis of Cytochrome P-450 2C9 Polymorphism and Colorectal Cancer Risk
- (2012) Shuo Liang et al. PLoS One
- The Influence of UGT1A6 Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma
- (2011) A. T. Chan et al. Cancer Prevention Research
- Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam
- (2010) Jung-Woo Bae et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Associations between polymorphisms in glucuronidation and sulfation enzymes and sex steroid concentrations in premenopausal women in the United States
- (2010) Mellissa Yong et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Multi-Variant Pathway Association Analysis Reveals the Importance of Genetic Determinants of Estrogen Metabolism in Breast and Endometrial Cancer Susceptibility
- (2010) Yen Ling Low et al. PLoS Genetics
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
- (2009) Jack Cuzick et al. LANCET ONCOLOGY
- No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk
- (2009) Cheryl L Thompson et al. WORLD JOURNAL OF GASTROENTEROLOGY
- A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia
- (2008) J T Cross et al. PHARMACOGENOMICS JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation